BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27884580)

  • 1. A benzimidazole derivative (RCB20) in vitro induces an activation of energetic pathways on Taenia crassiceps (ORF strain) cysticerci.
    Fraga CM; da Costa TL; de Castro AM; Reynoso-Ducoing O; Ambrosio J; Hernández-Campos A; Castillo R; Vinaud MC
    Exp Parasitol; 2017 Jan; 172():12-17. PubMed ID: 27884580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative energy production pathways in Taenia crassiceps cysticerci in vitro exposed to a benzimidazole derivative (RCB20).
    Fraga CM; Da Costa TL; De Castro AM; Reynoso-Ducoing O; Ambrosio J; Hernández-Campos A; Castillo R; Vinaud MC
    Parasitology; 2016 Apr; 143(4):488-93. PubMed ID: 26707797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benzimidazole derivative (RCB15) in vitro induces the alternative energetic metabolism and glycolysis in Taenia crassiceps cysticerci.
    de Andrade Picanço G; de Lima NF; Fraga CM; da Costa TL; Isac E; Ambrosio J; Castillo R; Vinaud MC
    Acta Trop; 2017 Dec; 176():288-292. PubMed ID: 28865900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RCB20, an experimental benzimidazole derivative, affects tubulin expression and induces gross anatomical changes in Taenia crassiceps cysticerci.
    Márquez-Navarro A; Pérez-Reyes A; Zepeda-Rodríguez A; Reynoso-Ducoing O; Hernández-Campos A; Hernández-Luis F; Castillo R; Yépez-Mulia L; Ambrosio JR
    Parasitol Res; 2013 Jun; 112(6):2215-26. PubMed ID: 23504054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci.
    Fraga CM; Costa TL; Bezerra JC; de Souza Lino R; Vinaud MC
    Exp Parasitol; 2012 Feb; 130(2):146-51. PubMed ID: 22127328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial inhibition of the tricarboxylic acid cycle in Taenia crassiceps cysticerci after the in vitro exposure to a benzimidazole derivative (RCB15).
    Picanço GA; Lima NF; Alves DS; Fraga CM; Costa TL; Junior RSL; Castillo R; Hernández-Campos A; Ambrosio J; Vinaud MC
    Acta Trop; 2020 Feb; 202():105254. PubMed ID: 31689380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro nitazoxanide exposure affects energetic metabolism of Taenia crassiceps.
    Isac E; Picanço GA; Costa TL; Lima NF; Alves DSMM; Fraga CM; Lino Junior RS; Vinaud MC
    Exp Parasitol; 2020 Jan; 208():107792. PubMed ID: 31707003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitazoxanide induces in vitro metabolic acidosis in Taenia crassiceps cysticerci.
    Isac E; de A Picanço G; da Costa TL; de Lima NF; de S M M Alves D; Fraga CM; de S Lino Junior R; Vinaud MC
    Exp Parasitol; 2016 Dec; 171():17-22. PubMed ID: 27751770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taenia crassiceps: energetic and respiratory metabolism from cysticerci exposed to praziquantel and albendazole in vitro.
    Vinaud MC; Ferreira CS; Lino Junior Rde S; Bezerra JC
    Exp Parasitol; 2008 Nov; 120(3):221-6. PubMed ID: 18694746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial inhibition of the main energetic pathways and its metabolic consequences after
    Picanço GA; de Lima NF; Gomes TC; Fraga CM; Alves DSMM; Castillo R; da Costa TL; Lino-Junior RS; Ambrosio J; Vinaud MC
    Parasitology; 2019 Oct; 146(12):1578-1582. PubMed ID: 31303189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acids oxidation and alternative energy sources detected in Taenia crassiceps cysticerci after host treatment with antihelminthic drugs.
    Fraga CM; Costa TL; Bezerra JC; de Souza Lino Junior R; Vinaud MC
    Exp Parasitol; 2012 May; 131(1):111-5. PubMed ID: 22465501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taenia crassiceps: fatty acids oxidation and alternative energy source in in vitro cysticerci exposed to anthelminthic drugs.
    Vinaud MC; Ferreira CS; Lino Junior Rde S; Bezerra JC
    Exp Parasitol; 2009 Jul; 122(3):208-11. PubMed ID: 19348802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the effects of cysticidal drugs in the Taenia crassiceps cysticerci ORF strain using the fluorescent CellTracker CMFDA.
    Trejo-Chávez H; García-Vilchis D; Reynoso-Ducoing O; Ambrosio JR
    Exp Parasitol; 2011 Jan; 127(1):294-9. PubMed ID: 20599436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci.
    Lima NF; Picanço GA; Alves DSMM; Silva LD; Isac E; Costa TL; Lino Junior RS; Vinaud MC
    Acta Trop; 2019 Feb; 190():361-364. PubMed ID: 30553893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taenia crassiceps organic acids detected in cysticerci.
    Vinaud MC; Lino Rde S; Bezerra JC
    Exp Parasitol; 2007 Aug; 116(4):335-9. PubMed ID: 17346707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci.
    Silva LD; Arrúa EC; Pereira DA; Fraga CM; Costa TL; Hemphill A; Salomon CJ; Vinaud MC
    Acta Trop; 2016 Sep; 161():100-5. PubMed ID: 27269203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis.
    Nasareth JM; Fraga CM; Lima NF; Picanço GA; Costa TL; Lino-Junior RS; Vinaud MC
    Parasitol Res; 2017 Nov; 116(11):3037-3041. PubMed ID: 28914356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.
    Palomares-Alonso F; Piliado JC; Palencia G; Ortiz-Plata A; Jung-Cook H
    J Antimicrob Chemother; 2007 Feb; 59(2):212-8. PubMed ID: 17114175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of anthelminthic drugs in the larval stage of the cestode Taenia crassiceps, cysticercosis experimental model - A review.
    Vinaud MC; Ambrosio J
    Acta Trop; 2020 Jun; 206():105448. PubMed ID: 32194066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide.
    de Andrade Picanço G; Ferreira de Lima N; Cristina Gomes T; de Sousa Mendes Moreira Alves D; Luísa da Costa T; Vinaud MC
    Acta Trop; 2022 Feb; 226():106264. PubMed ID: 34919953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.